Q-omics provides the consensus-scored LINC02078 profile across patient tissues and cancer cell-line models. LINC02078 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, LINC02078 is differentially expressed in 8, with the highest sampling consensus in KIRC. Additionally, LINC02078 RNA expression shows 12,596 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight ACC, KIRC, and TGCT as cancer lineages where LINC02078 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02078 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02078 survival associations across molecular data types. LINC02078 RNA expression shows survival associations in the most cancer types (21), followed by mutation status (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02078 RNA expression–survival associations across cancer types. High LINC02078 expression shows unfavorable associations in ACC, UVM, LIHC, KIRC and GBM, but favorable associations in CESC. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for LINC02078 RNA expression.
This table summarizes LINC02078 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02078. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02078 shows lower tumor expression in BLCA, UCEC and COAD and higher tumor expression in KIRC, HNSC and LIHC. The KIRC box plot shows higher LINC02078 RNA expression in tumor versus normal tissue (log2 FC = +0.047, t-test p < 0.001).
This table shows molecular features associated with LINC02078 in patient tissues and cancer cell lines. In patient samples, LINC02078 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
